Italy: Stevanato clears way for US IPO with registration document

Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has filed a registration statement with the US Securities and Exchange Commission (SEC) relating to a proposed IPO of ordinary shares. The offering will consist of a portion of new shares and a sale…

You must be a HMI Subscriber to view this content.

Subscribe Now »